Volume 17, 2013

Sign On

Volume 17, 2013 CD
Six back issues from 2013 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 17 No. 1	January/February 2013	Volume 17, Number 1
Vol. 17 No. 2	March/April 2013	Volume 17, Number 2
Vol. 17 No. 3	May/June 2013	Volume 17, Number 3
Vol. 17 No. 4	July/August 2013	Volume 17, Number 4
Vol. 17 No. 5	September/October 2013	Volume 17, Number 5
Vol. 17 No. 6	November/December 2013	Volume 17, Number 6

Volume 17, 2013 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 17, 2013 CD ARTICLES
PreScription: How Many Pharmacies Compound and What Do They Compound?	Vol. 17 No. 1	4
PreScription: Looking for Solutions	Vol. 17 No. 1	4
Pediatric Health Care: An Introduction	Vol. 17 No. 1	6
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients	Vol. 17 No. 1	10
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?	Vol. 17 No. 1	24
Treatment Options for Male Hypogonadism	Vol. 17 No. 1	28
Adrenal Fatigue	Vol. 17 No. 1	39
International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives	Vol. 17 No. 1	48
Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves	Vol. 17 No. 1	50
Basics of Compounding: Repackaging, Part 1	Vol. 17 No. 1	54
Calculations	Vol. 17 No. 1	62
Desmopressin 4-mcg/mL Injection	Vol. 17 No. 1	64
Dobutamine 10-mg/mL Injection	Vol. 17 No. 1	65
Granisetron 1-mg/mL Injection	Vol. 17 No. 1	66
Ibuprofen 10-mg/mL Injection	Vol. 17 No. 1	67
Mepivacaine Hydrochloride 1% Injection	Vol. 17 No. 1	68
Milrinone 0.2-mg/mL Injection	Vol. 17 No. 1	69
Neostigmine Methylsulfate 0.5-mg/mL Injection	Vol. 17 No. 1	70
Nicardipine Hydrochloride Injection	Vol. 17 No. 1	71
Octreotide 50-mcg/mL Injection	Vol. 17 No. 1	72
Testosterone Cypionate 100-mg/mL Injection	Vol. 17 No. 1	73
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women	Vol. 17 No. 1	74
Errata	Vol. 17 No. 1	86
PostScription: GMPs and GCPs: A Topical Comparison	Vol. 17 No. 1	87
PreScription: Pharmacy Committees	Vol. 17 No. 2	92
Sterilization of Compounded Parenteral Products: Verification of Autoclaves	Vol. 17 No. 2	94
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists	Vol. 17 No. 2	100
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities	Vol. 17 No. 2	113
Compounding in Ukraine	Vol. 17 No. 2	124
International Academy of Compounding Pharmacists Legislative/Regulatory Update	Vol. 17 No. 2	128
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program	Vol. 17 No. 2	130
Basics of Compounding: Repackaging, Part 2	Vol. 17 No. 2	136
Calculations	Vol. 17 No. 2	142
Adenosine 3-mg/mL Injection	Vol. 17 No. 2	144
Alcohol Dehydrated Injection	Vol. 17 No. 2	145
Betahistine 16-mg Capsules	Vol. 17 No. 2	146
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate	Vol. 17 No. 2	147
Cyanocobalamin 1000-mcg/mL Injection	Vol. 17 No. 2	148
Dexrazoxane 1-mg/mL Injection	Vol. 17 No. 2	149
Meropenem 50-mg/mL Injection	Vol. 17 No. 2	150
Paclitaxel 6-mg/mL Injection	Vol. 17 No. 2	151
Thiotepa 15-mg/mL Injection	Vol. 17 No. 2	152
Verapamil Hydrochloride 2.5-mg/mL Injection	Vol. 17 No. 2	153
Compounding Practices and Beliefs of Arizona Pharmacists	Vol. 17 No. 2	154
Stability of Rifampin in SyrSpend SF	Vol. 17 No. 2	162
Stability of Minoxidil in Espumil Foam Base	Vol. 17 No. 2	165
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings	Vol. 17 No. 2	168
PreScription: Compounding for Drug Shortages	Vol. 17 No. 3	180
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists	Vol. 17 No. 3	182
Decontamination Technology: The Missing Element	Vol. 17 No. 3	193
Optimizing Third-party Reimbursement for Compounded Medications	Vol. 17 No. 3	201
International Academy of Compounding Pharmacists' Legislative/Regulatory Update	Vol. 17 No. 3	206
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations	Vol. 17 No. 3	210
Basics of Compounding: Potency and Stability Testing	Vol. 17 No. 3	220
Calculations	Vol. 17 No. 3	226
Buffered Aspirin Capsules	Vol. 17 No. 3	228
Calcium Acetate 667-mg Capsules	Vol. 17 No. 3	229
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules	Vol. 17 No. 3	230
Ethambutol 400-mg Capsules	Vol. 17 No. 3	231
Isoniazid 300-mg Capsules	Vol. 17 No. 3	232
Labetalol 50-mg Capsules	Vol. 17 No. 3	233
Mercaptopurine 75-mg Capsules	Vol. 17 No. 3	234
Naltrexone Hydrochloride 50-mg Capsules	Vol. 17 No. 3	235
Prednisone 10-mg Capsules	Vol. 17 No. 3	236
Reserpine 0.5-mg Capsules	Vol. 17 No. 3	237
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines	Vol. 17 No. 3	238
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel	Vol. 17 No. 3	247
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline	Vol. 17 No. 3	254
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial	Vol. 17 No. 3	262
Prescription: International Journal of Pharmaceutical Compounding and MEDLINE Update	Vol. 17 No. 4	268
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents	Vol. 17 No. 4	270
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013	Vol. 17 No. 4	283
Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover	Vol. 17 No. 4	290
Types of Pharmacy/Pharmacists	Vol. 17 No. 4	294
International Academy of Compounding Pharmacists Legislative/Regulatory Update	Vol. 17 No. 4	302
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations	Vol. 17 No. 4	307
Basics of Compounding: Foam Dosage Forms	Vol. 17 No. 4	312
Calculations	Vol. 17 No. 4	324
Acyclovir 20-mg/mL Oral Suspension	Vol. 17 No. 4	326
Acyclovir 200-mg Capsules	Vol. 17 No. 4	327
Allopurinol Sodium 4-mg/mL Injection	Vol. 17 No. 4	328
Amikacin Sulfate 250-mg/mL Injection	Vol. 17 No. 4	329
Dacarbazine 200-mg/mL Injection	Vol. 17 No. 4	330
Ketamine 50-mg/mL Injection	Vol. 17 No. 4	331
Methohexital Sodium 500-mg/mL Injection	Vol. 17 No. 4	332
Metoprolol Tartrate 1-mg/mL Injection	Vol. 17 No. 4	333
Rifampin 300-mg and Isoniazid 150-mg Capsules	Vol. 17 No. 4	334
Succinylcholine Chloride 50-mg/mL Injection	Vol. 17 No. 4	335
Stability of Captopril in SyrSPend SF	Vol. 17 No. 4	336
Patient-centered Care as Value-added Service by Compounding Pharmacists	Vol. 17 No. 4	339
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry	Vol. 17 No. 4	344
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs	Vol. 17 No. 4	347
PostScription: Traditional vs Nontraditional Pharmacy	Vol. 17 No. 4	351
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions	Vol. 17 No. 5	356
Compounding Pharmacies: Before and After an Inspection	Vol. 17 No. 5	358
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms	Vol. 17 No. 5	364
Chemical Penetration Enhancers	Vol. 17 No. 5	370
2013 State Compounding Legislation Tracker Updated: August 12, 2013	Vol. 17 No. 5	375
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease	Vol. 17 No. 5	380
Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines	Vol. 17 No. 5	384
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1	Vol. 17 No. 5	388
Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach	Vol. 17 No. 5	393
Basics of Compounding: Basics of Compounding with Tars	Vol. 17 No. 5	400
Calculations	Vol. 17 No. 5	412
Acyclovir 50-mg/mL Injection	Vol. 17 No. 5	414
Aminocaproic Acid 250-mg/mL Injection	Vol. 17 No. 5	415
Clindamycin 150-mg/mL Injection	Vol. 17 No. 5	416
Fluorouracil 50-mg/mL Injection	Vol. 17 No. 5	417
Hydroxyzine Hydrochloride 25-mg/mL Injection	Vol. 17 No. 5	418
Indomethacin 1-mg/mL Injection	Vol. 17 No. 5	419
Mesna 100-mg/mL Injection	Vol. 17 No. 5	420
Methotrexate 25-mg/mL Injection	Vol. 17 No. 5	421
Phenylephrine Hydrochloride 10-mg/mL Injection	Vol. 17 No. 5	422
Terbutaline Sulfate 1-mg/mL Injection	Vol. 17 No. 5	423
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs	Vol. 17 No. 5	424
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment	Vol. 17 No. 5	432
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration	Vol. 17 No. 5	436
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters	Vol. 17 No. 5	439
PreScription: Two Milestones for the International Journal of Pharmaceutical Compounding	Vol. 17 No. 6	444
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2	Vol. 17 No. 6	446
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy	Vol. 17 No. 6	452
Considerations for Pharmacists Working in Major Disaster Areas	Vol. 17 No. 6	459
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies	Vol. 17 No. 6	465
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding	Vol. 17 No. 6	477
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now?	Vol. 17 No. 6	480
Marketing During the Holidays	Vol. 17 No. 6	482
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety	Vol. 17 No. 6	485
Basics of Compounding: Basics of Compounding with Balsams	Vol. 17 No. 6	490
Calculations	Vol. 17 No. 6	496
Benztropine Mesylate 1-mg/mL Injection	Vol. 17 No. 6	498
Cefazolin 250-mg/mL Injection	Vol. 17 No. 6	499
Ciprofloxacin 250-mg Capsules	Vol. 17 No. 6	500
Cortisone Acetate 25-mg Capsules	Vol. 17 No. 6	501
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution	Vol. 17 No. 6	502
Dihydroergotamine Mesylate 1-mg/mL Injection	Vol. 17 No. 6	503
Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)	Vol. 17 No. 6	504
Levothyroxine Sodium 100-mcg Capsules	Vol. 17 No. 6	505
Metyrosine 250-mg Capsules	Vol. 17 No. 6	506
Phenytoin Sodium 50-mg/mL Injection	Vol. 17 No. 6	507
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles	Vol. 17 No. 6	508
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds	Vol. 17 No. 6	512
Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes	Vol. 17 No. 6	515
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream	Vol. 17 No. 6	520
PostScription: Augmented Reality for Readers and Authors	Vol. 17 No. 6	526